BioSpecifics Technologies Corp. Company Profile (NASDAQ:BSTC)

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. logoBioSpecifics Technologies Corp. (BioSpecifics) is a biopharmaceutical company. The Company is engaged in the development of an injectable collagenase clostridium histolyticum (CCH) for multiple indications. The Company has a development and license agreement with Endo International plc (Endo) for injectable collagenases for marketed indications and indications in development. CCH is marketed as XIAFLEX and as XIAPEX in Europe. Its injectable collagenases are marketed for indications, such as Dupuytren's contracture and Peyronie's disease. BioSpecifics is conducting development work with respect to human lipoma and uterine fibroids. XIAFLEX and XIAPEX are approved in the United States, the European Union, Switzerland, Canada, Australia and Japan for the treatment of Dupuytren's contracture. Endo manages the research and development of XIAFLEX for their licensed indications, including frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis and uterine fibroids.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: BSTC
  • CUSIP: 09093110
Key Metrics:
  • Previous Close: $44.04
  • 50 Day Moving Average: $38.92
  • 200 Day Moving Average: $37.74
  • 52-Week Range: $7,012,000.00 - $30.70
  • Trailing P/E Ratio: 30.40
  • Foreward P/E Ratio: 26.31
  • P/E Growth: 1.31
  • Market Cap: $317.36M
  • Outstanding Shares: 7,012,000
  • Beta: 1.22
Profitability:
  • Net Margins: 43.42%
  • Return on Equity: 23.71%
  • Return on Assets: 21.42%
Debt:
  • Current Ratio: 29.25%
  • Quick Ratio: 29.25%
Additional Links:
Companies Related to BioSpecifics Technologies Corp.:

Analyst Ratings

Consensus Ratings for BioSpecifics Technologies Corp. (NASDAQ:BSTC) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $60.00 (32.57% upside)

Analysts' Ratings History for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
Show:
DateFirmActionRatingPrice TargetDetails
8/10/2016Rodman & RenshawReiterated RatingBuy$60.00View Rating Details
3/8/2016HC WainwrightReiterated RatingBuyView Rating Details
7/16/2015MLV & Co.Initiated CoverageBuy$76.00View Rating Details
12/23/2014AegisReiterated RatingPositiveView Rating Details
11/11/2014MKM PartnersBoost Price TargetBuy$38.00 -> $46.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216$0.35$0.37$6.25 million$6.20 millionViewN/AView Earnings Details
5/10/2016Q116$0.37$0.39$6.25 million$6.60 millionViewListenView Earnings Details
3/14/2016Q416$0.33$0.36$4.60 million$6.10 millionViewListenView Earnings Details
11/9/2015Q315$0.39$7.51 million$6.30 millionViewN/AView Earnings Details
8/10/2015Q215$0.44$0.24$2.60 million$4.70 millionViewListenView Earnings Details
5/11/2015Q414$0.32$2.30 million$5.60 millionViewN/AView Earnings Details
11/10/2014Q314$0.19$0.21$4.00 million$4.00 millionViewN/AView Earnings Details
8/11/2014Q214$0.12$0.09$2.91 million$2.70 millionViewN/AView Earnings Details
5/8/2014Q114$0.07$0.12$2.46 million$2.80 millionViewN/AView Earnings Details
3/6/2014$0.17$0.25ViewN/AView Earnings Details
11/12/2013Q3$0.04$0.17ViewListenView Earnings Details
8/8/2013Q2 2013$0.02$0.15ViewN/AView Earnings Details
5/10/2013Q1 2013$0.18$0.19ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
Current Year EPS Consensus Estimate: $1.53 EPS
Next Year EPS Consensus Estimate: $1.72 EPS

Dividends

Dividend History for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
Insider Ownership Percentage: 23.19%
Institutional Ownership Percentage: 55.78%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2016Thomas WegmanInsiderSell3,100$41.21$127,751.00View SEC Filing  
9/13/2016Thomas WegmanInsiderSell3,605$37.55$135,367.75View SEC Filing  
9/2/2016Thomas WegmanInsiderSell9,201$37.53$345,313.53View SEC Filing  
8/30/2016Thomas WegmanInsiderSell4,299$37.54$161,384.46View SEC Filing  
8/24/2016Thomas WegmanPresidentSell4,173$38.08$158,907.84View SEC Filing  
8/23/2016Thomas WegmanPresidentSell4,100$38.60$158,260.00View SEC Filing  
5/18/2016Thomas WegmanMajor ShareholderSell50,000$33.01$1,650,500.00View SEC Filing  
5/18/2016Toby WegmanDirectorSell25,000$33.01$825,250.00View SEC Filing  
11/30/2015Thomas WegmanCEOSell2,000$50.00$100,000.00View SEC Filing  
11/23/2015Thomas WegmanCEOSell14,000$50.09$701,260.00View SEC Filing  
11/18/2015Thomas WegmanCEOSell10,849$50.08$543,317.92View SEC Filing  
11/16/2015Thomas WegmanCEOSell27,151$52.44$1,423,798.44View SEC Filing  
7/20/2015Paul GitmanDirectorSell8,692$53.00$460,676.00View SEC Filing  
6/23/2015Paul GitmanDirectorSell36,308$51.78$1,880,028.24View SEC Filing  
5/29/2015Paul GitmanDirectorSell15,000$46.76$701,400.00View SEC Filing  
5/27/2015Paul GitmanDirectorSell24,000$42.00$1,008,000.00View SEC Filing  
1/23/2015Paul GitmanDirectorSell5,887$41.00$241,367.00View SEC Filing  
1/16/2015Paul GitmanDirectorSell4,113$41.00$168,633.00View SEC Filing  
11/24/2014Toby WegmanDirectorSell12,050$39.07$470,793.50View SEC Filing  
11/14/2014Michael SchamrothDirectorSell5,200$39.20$203,840.00View SEC Filing  
11/14/2014Thomas WegmanMajor ShareholderSell40,000$38.96$1,558,400.00View SEC Filing  
6/20/2014Jeffrey Kenneth VogelInsiderSell88,329$27.43$2,422,864.47View SEC Filing  
6/12/2014Paul GitmanDirectorSell10,000$28.00$280,000.00View SEC Filing  
6/4/2014Henry MorganDirectorSell17,940$27.00$484,380.00View SEC Filing  
6/2/2014Henry MorganDirectorSell2,060$27.01$55,640.60View SEC Filing  
5/29/2014Henry MorganDirectorSell20,000$27.03$540,600.00View SEC Filing  
5/19/2014Henry MorganDirectorSell20,000$25.84$516,800.00View SEC Filing  
1/23/2014Paul GitmanDirectorSell10,000$25.00$250,000.00View SEC Filing  
12/9/2013Paul GitmanDirectorSell15,000$23.00$345,000.00View SEC Filing  
11/11/2013Paul GitmanDirectorSell5,000$20.00$100,000.00View SEC Filing  
9/5/2013Henry MorganDirectorSell17,850$18.48$329,868.00View SEC Filing  
9/3/2013Henry MorganDirectorSell2,150$18.35$39,452.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioSpecifics Technologies Corp. (NASDAQ:BSTC)
DateHeadline
News IconBioSpecifics Technologies Corp. (BSTC) Receives “Buy” Rating from Rodman & Renshaw - DailyQuint (NASDAQ:BSTC)
dailyquint.com - September 23 at 3:25 PM
finance.yahoo.com logoBioSpecifics Technologies (BSTC) Catches Eye: Stock Up 5.2% (NASDAQ:BSTC)
finance.yahoo.com - September 21 at 3:25 PM
finance.yahoo.com logoCan The Uptrend Continue for BioSpecifics Technologies (BSTC)? (NASDAQ:BSTC)
finance.yahoo.com - September 20 at 9:52 AM
News IconRodman & Renshaw Reaffirms “Buy” Rating for BioSpecifics Technologies Corp. (BSTC) - DailyQuint (NASDAQ:BSTC)
dailyquint.com - September 19 at 8:46 AM
News IconThomas Wegman an Insider in BioSpecifics Technologies Corp. (NASDAQ:BSTC) Unloaded 3100 Shares of the ... - Post News (NASDAQ:BSTC)
www.kentuckypostnews.com - September 17 at 3:53 PM
News IconBiospecifics Tech Corporation (NASDAQ:BSTC) Short Interest Decreased By 2.3% - Post News (NASDAQ:BSTC)
www.kentuckypostnews.com - September 16 at 3:55 PM
News IconBiospecifics Tech Corporation (NASDAQ:BSTC) Short Interest Decreased By 2.3% - Post News (NASDAQ:BSTC)
www.kentuckypostnews.com - September 16 at 3:55 PM
zacks.com logoFoamix Pharmaceuticals (FOMX) Jumps: Stock Rises 15.7% (NASDAQ:BSTC)
www.zacks.com - September 13 at 8:51 AM
zacks.com logoNew Strong Buy Stocks for September 7th (NASDAQ:BSTC)
www.zacks.com - September 7 at 10:32 AM
finance.yahoo.com logoBioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences (NASDAQ:BSTC)
finance.yahoo.com - September 2 at 8:44 AM
zacks.com logoDipexium Pharmaceuticals (DPRX) in Focus: Stock Gains 8.5% (NASDAQ:BSTC)
www.zacks.com - September 1 at 12:28 PM
finance.yahoo.com logoWhat Makes Collegium Pharmaceutical (COLL) a Strong Sell? (NASDAQ:BSTC)
finance.yahoo.com - August 30 at 11:48 AM
zacks.com logoWeakness Seen in Jazz Pharmaceuticals (JAZZ) Estimates: Should You Stay Away? (NASDAQ:BSTC)
www.zacks.com - August 29 at 3:20 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Mylan, Teva Pharmaceutical, Lannett Company, BioSpecifics Technologies and USANA Health Sciences (NASDAQ:BSTC)
finance.yahoo.com - August 29 at 3:20 PM
capitalcube.com logoETF’s with exposure to Biospecifics Technologies Corp. : August 23, 2016 (NASDAQ:BSTC)
www.capitalcube.com - August 23 at 4:02 PM
capitalcube.com logoBiospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:BSTC)
www.capitalcube.com - August 12 at 3:27 PM
sg.finance.yahoo.com logoBioSpecifics posts 2Q profit (NASDAQ:BSTC)
sg.finance.yahoo.com - August 9 at 10:35 PM
publicnow.com logoBioSpecifics Technologies Corp. Reports Second Quarter 2016 Financial Results (NASDAQ:BSTC)
www.publicnow.com - August 9 at 5:06 PM
biz.yahoo.com logoQ2 2016 Biospecifics Technologies Corp Earnings Release - Before Market Open (NASDAQ:BSTC)
biz.yahoo.com - August 9 at 12:56 PM
seekingalpha.com logoBioSpecifics Technologies Corp. Has A 6-Year Expiration Date (NASDAQ:BSTC)
seekingalpha.com - August 3 at 12:41 PM
finance.yahoo.com logoBioSpecifics Technologies Corp. to Report Second Quarter 2016 Financial Results on Tuesday, August 9, … (NASDAQ:BSTC)
finance.yahoo.com - August 2 at 4:06 PM
publicnow.com logoBioSpecifics Technologies Corp. to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016 (NASDAQ:BSTC)
www.publicnow.com - August 2 at 8:47 AM
finance.yahoo.com logoBioSpecifics Technologies Corp. Announces Positive Top-Line Results from Phase 2 Trial of CCH for Treatment of Human Lipoma (NASDAQ:BSTC)
finance.yahoo.com - June 13 at 4:14 PM
feeds.benzinga.com logoBioSpecifics Technologies Reveals Positive Top-Line Results From Stage 2 Study Of CCH For Treatment of Human Lipoma (NASDAQ:BSTC)
feeds.benzinga.com - June 13 at 10:19 AM
biz.yahoo.com logoBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:BSTC)
biz.yahoo.com - June 3 at 1:09 PM
streetinsider.com logoBiospecifics Technologies (BSTC) Announces Publication of Data for Uterine Fibroid Treatment with CCH (NASDAQ:BSTC)
www.streetinsider.com - May 31 at 4:00 PM
biz.yahoo.com logoBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:BSTC)
biz.yahoo.com - May 31 at 3:04 PM
publicnow.com logoBioSpecifics Technologies Corp. Announces Publication of Encouraging Data for Uterine Fibroid Treatment with CCH in American Journal of Obstetrics & Gynecology (NASDAQ:BSTC)
www.publicnow.com - May 31 at 7:52 AM
finance.yahoo.com logo7:31 am BioSpecifics Tech announces the publication of data on collagenase clostridium histolyticum for the treatment of uterine fibroids in the American Journal of Obstetrics & Gynecology (NASDAQ:BSTC)
finance.yahoo.com - May 31 at 7:31 AM
biz.yahoo.com logoBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification (NASDAQ:BSTC)
biz.yahoo.com - May 27 at 5:03 PM
capitalcube.com logoETF’s with exposure to Biospecifics Technologies Corp. : May 26, 2016 (NASDAQ:BSTC)
www.capitalcube.com - May 26 at 7:23 PM
investornewswire.com logoBioSpecifics Technologies Corp (NASDAQ:BSTC) Closes At $35.13 - Investor Newswire (NASDAQ:BSTC)
www.investornewswire.com - May 25 at 1:02 PM
News IconBiospecifics Tech Corporation (NASDAQ:BSTC) Shorts Decreased by 7.48% After Short Covering - Wall Street Hints and News (NASDAQ:BSTC)
hintsnewsnetwork.com - May 24 at 1:31 PM
investornewswire.com logoBioSpecifics Technologies Corp (NASDAQ:BSTC) Quarterly EPS From Continuing Operations Stands At $0.4035 - Investor Newswire (NASDAQ:BSTC)
www.investornewswire.com - May 24 at 1:31 PM
News IconWegman Toby, Director of BioSpecifics Technologies Corp (NASDAQ:BSTC) sells 25,000 shares (NASDAQ:BSTC)
empowerednews.net - May 24 at 1:31 PM
capitalcube.com logoBiospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 (NASDAQ:BSTC)
www.capitalcube.com - May 23 at 2:08 PM
equities.com logoBioSpecifics Technologies Corp. (BSTC) is Trading Lower on Unusual Volume for May 18 - Equities.com (NASDAQ:BSTC)
www.equities.com - May 21 at 12:52 PM
tradecalls.org logoRevenue Update on BioSpecifics Technologies Corp.(NASDAQ:BSTC) - Trade Calls (NASDAQ:BSTC)
www.tradecalls.org - May 21 at 12:52 PM
News IconBiospecifics Tech Corporation (NASDAQ:BSTC) Short Interest Decreased By 7.48% - Wall Street Hints and News (NASDAQ:BSTC)
hintsnewsnetwork.com - May 19 at 12:53 PM
publicnow.com logoBioSpecifics Technologies Corp. to Present at the 2016 UBS Global Healthcare Conference (NASDAQ:BSTC)
www.publicnow.com - May 18 at 7:42 AM
equities.com logoBioSpecifics Technologies Corp. (BSTC) Jumps 6.99% on May 10 - Equities.com (NASDAQ:BSTC)
www.equities.com - May 12 at 7:36 AM
marketexclusive.com logoBioSpecifics Technologies Corp. (NASDAQ:BSTC) Could Reverse on Topline Release (NASDAQ:BSTC)
marketexclusive.com - May 12 at 7:36 AM
twst.com logoBioSpecifics Technologies Corp.: BioSpecifics Technologies Corp. Reports First Quarter 2016 Financial Results (NASDAQ:BSTC)
www.twst.com - May 11 at 6:54 AM
publicnow.com logoBioSpecifics Technologies Corp. Reports First Quarter 2016 Financial Results (NASDAQ:BSTC)
www.publicnow.com - May 10 at 7:48 AM
biz.yahoo.com logoBIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement (NASDAQ:BSTC)
biz.yahoo.com - May 10 at 7:47 AM
sg.finance.yahoo.com logoBioSpecifics posts 1Q profit (NASDAQ:BSTC)
sg.finance.yahoo.com - May 10 at 7:40 AM
biz.yahoo.com logoQ1 2016 Biospecifics Technologies Corp Earnings Release - Before Market Open (NASDAQ:BSTC)
biz.yahoo.com - May 10 at 7:07 AM
News IconLatest Analyst Ratings For BioSpecifics Technologies Corp (BSTC) - Share Trading News (NASDAQ:BSTC)
www.sharetrading.news - May 5 at 7:14 AM
publicnow.com logoBioSpecifics Technologies Corp. to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016 (NASDAQ:BSTC)
www.publicnow.com - May 3 at 8:10 AM
investornewswire.com logoBioSpecifics Technologies Corp (NASDAQ:BSTC) Basic Consolidated EPS At $1.4087 - Investor Newswire (NASDAQ:BSTC)
www.investornewswire.com - April 26 at 7:44 AM

Social

BioSpecifics Technologies Corp. (NASDAQ:BSTC) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff